Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 287

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 12
Chunk 287
---
 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  
    32.1#
     
    Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002
  
    32.2#
     
    Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002
  
    97.1
     
    Indaptus Therapeutics, Inc. Policy for Recovery of Erroneously Awarded Compensation (incorporated herein by reference to Exhibit 97.1 of the Company’s Annual Report on Form 10-K filed with the SEC on March 13, 2024)
  
    101.INS*
     
    Inline XBRL Instance Document
    (the Instance Document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document)
  
    101.SCH*
     
    Inline XBRL Taxonomy Extension
    Schema Document
  
    101.CAL*
     
    Inline XBRL Taxonomy Extension
    Calculation Linkbase Document
  
    101.DEF*
     
    Inline XBRL Taxonomy Extension
    Definition Linkbase Document
  
    101.LAB*
     
    Inline XBRL Taxonomy Extension
    Labels Linkbase Document
  
    101.PRE*
     
    Inline XBRL Taxonomy Extension
    Presentation Linkbase Document
  
    104
     
    Cover Page Interactive
    Data File (formatted as Inline XBRL and contained in Exhibits 101)

    *
    Filed herewith

    #
    Furnished herewith

    +
    Indicates management contract or compensatory plan.

    ++ 
    The schedules to the agreement
    have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule will be furnished to the SEC upon
    request.

Item
16. Form 10-K Summary

None.

96

SIGNATURES

Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report
to be signed